Kristina Sauerwein
Articles
-
Jan 22, 2025 |
source.washu.edu | Kristina Sauerwein |Brittney Wheeler
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity. Formally, these drugs are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and Zepbound.
-
Jan 21, 2025 |
megadoctornews.com | Kristina Sauerwein
Mega Doctor NewsBy Kristina Sauerwein / Washington University in St. LouisNewswise – Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity. Formally, these drugs are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and Zepbound.
-
Jan 16, 2025 |
source.washu.edu | Kristina Sauerwein
Flint Fowler, a strong champion for St. Louis’ young people and a WashU alumnus, will receive the annual Rosa L. Parks Award at the 38th annual Dr. Martin Luther King Jr. Commemoration at 2 p.m. Monday, Jan. 20, in Graham Chapel at Washington University in St. Louis. In addition, WashU Medicine will hold a series of events as part of its Martin Luther King Jr. Commemoration Week. Fowler retired in December from Boys & Girls Clubs of St. Louis, where he served as executive director for 28 years.
-
Jan 15, 2025 |
msn.com | Kristina Sauerwein
Continue reading More for You
-
Jan 15, 2025 |
medicalxpress.com | Kristina Sauerwein
Researchers at Washington University School of Medicine in St. Louis have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition. In their latest study, a team led by Jonathan Cooper, Ph.D., professor of pediatrics at WashU Medicine, has shown that gene therapy to the bowel in mice modeling Batten disease reduced symptoms and extended lifespan. The study is published in the journal Science Translational Medicine.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →